These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 37760455)
1. Acceptability and Usability of the Family Gene Toolkit for Swiss and Korean Families Harboring Baroutsou V; Duong V; Signorini A; Saccilotto R; Ciorba FM; Bürki N; Caiata-Zufferey M; Ryu JM; Kim SW; Lim MC; Monnerat C; Zürrer-Härdi U; Kim J; Heinimann K; Graffeo R; Park JS; Rabaglio M; Chappuis PO; Kim S; Katapodi MC; On Behalf Of The Cascade And K-Cascade Consortia Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760455 [TBL] [Abstract][Full Text] [Related]
2. Using a Tailored Digital Health Intervention for Family Communication and Cascade Genetic Testing in Swiss and Korean Families With Hereditary Breast and Ovarian Cancer: Protocol for the DIALOGUE Study. Kim S; Aceti M; Baroutsou V; Bürki N; Caiata-Zufferey M; Cattaneo M; Chappuis PO; Ciorba FM; Graffeo-Galbiati R; Heinzelmann-Schwarz V; Jeong J; Jung MM; Kim SW; Kim J; Lim MC; Ming C; Monnerat C; Park HS; Park SH; Pedrazzani CA; Rabaglio M; Ryu JM; Saccilotto R; Wieser S; Zürrer-Härdi U; Katapodi MC JMIR Res Protoc; 2021 Jun; 10(6):e26264. PubMed ID: 34114954 [TBL] [Abstract][Full Text] [Related]
3. Development of a Web-based Family Intervention for BRCA Carriers and Their Biological Relatives: Acceptability, Feasibility, and Usability Study. Katapodi MC; Jung M; Schafenacker AM; Milliron KJ; Mendelsohn-Victor KE; Merajver SD; Northouse LL JMIR Cancer; 2018 Apr; 4(1):e7. PubMed ID: 29653920 [TBL] [Abstract][Full Text] [Related]
4. Communication about positive BRCA1 and BRCA2 genetic test results and uptake of testing in relatives in a diverse Asian setting. Lee DS; Meiser B; Mariapun S; Hassan T; Yip CH; Mohd Taib NA; Teo SH; Thong MK; Yoon SY J Genet Couns; 2021 Jun; 30(3):720-729. PubMed ID: 33245177 [TBL] [Abstract][Full Text] [Related]
5. Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol. Katapodi MC; Viassolo V; Caiata-Zufferey M; Nikolaidis C; Bührer-Landolt R; Buerki N; Graffeo R; Horváth HC; Kurzeder C; Rabaglio M; Scharfe M; Urech C; Erlanger TE; Probst-Hensch N; Heinimann K; Heinzelmann-Schwarz V; Pagani O; Chappuis PO JMIR Res Protoc; 2017 Sep; 6(9):e184. PubMed ID: 28931501 [TBL] [Abstract][Full Text] [Related]
6. Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort. Sarki M; Ming C; Aissaoui S; Bürki N; Caiata-Zufferey M; Erlanger TE; Graffeo-Galbiati R; Heinimann K; Heinzelmann-Schwarz V; Monnerat C; Probst-Hensch N; Rabaglio M; Zürrer-Härdi U; Chappuis PO; Katapodi MC; On Behalf Of The Cascade Consortium Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406409 [TBL] [Abstract][Full Text] [Related]
7. Web-Based Tool (FH Family Share) to Increase Uptake of Cascade Testing for Familial Hypercholesterolemia: Development and Evaluation. Bangash H; Makkawy A; Gundelach JH; Miller AA; Jacobson KA; Kullo IJ JMIR Hum Factors; 2022 Feb; 9(1):e32568. PubMed ID: 35166678 [TBL] [Abstract][Full Text] [Related]
8. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds. Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920 [TBL] [Abstract][Full Text] [Related]
9. Modes of responsibility in disclosing cancer genetic test results to relatives: An analysis of Swiss and Korean narrative data. Aceti M; Caiata-Zufferey M; Pedrazzani C; Schweighoffer R; Kim SY; Baroutsou V; Katapodi MC; Kim S; Patient Educ Couns; 2024 Jun; 123():108202. PubMed ID: 38395023 [TBL] [Abstract][Full Text] [Related]
11. The impact of a cascade testing video on recipients' knowledge, cognitive message processing, and affective reactions: A formative evaluation. Aeilts AM; Carpenter KM; Hovick SR; Byrne L; Shoben AB; Senter L J Genet Couns; 2021 Jun; 30(3):656-664. PubMed ID: 33142025 [TBL] [Abstract][Full Text] [Related]
12. Family health beliefs and cascade genetic testing in Asian families with hereditary cancer risk: "Okay, now what?". Tran L; Young JL; Barton CM; Hodan R; Hanson-Kahn A; Chun N J Genet Couns; 2024 Mar; ():. PubMed ID: 38504135 [TBL] [Abstract][Full Text] [Related]
13. Patients' attitudes regarding genetic counseling before germline BRCA1/2 pathogenic variants testing in Taiwan: A single-country, multi-center, patient-reported outcome study. Kuo WL; Lin PH; Peng MT; Chu CH; Cho CW J Genet Couns; 2023 Aug; 32(4):788-797. PubMed ID: 36872635 [TBL] [Abstract][Full Text] [Related]
14. The Genetic Education for Men (GEM) Trial: Development of Web-Based Education for Untested Men in BRCA1/2-Positive Families. Peshkin BN; Ladd MK; Isaacs C; Segal H; Jacobs A; Taylor KL; Graves KD; O'Neill SC; Schwartz MD J Cancer Educ; 2021 Feb; 36(1):72-84. PubMed ID: 31402434 [TBL] [Abstract][Full Text] [Related]
15. The uptake of predictive DNA testing in 40 families with a pathogenic BRCA1/BRCA2 variant. An evaluation of the proband-mediated procedure. Menko FH; Jeanson KN; Bleiker EMA; van Tiggelen CWM; Hogervorst FBL; Ter Stege JA; Ait Moha D; van der Kolk LE Eur J Hum Genet; 2020 Aug; 28(8):1020-1027. PubMed ID: 32300191 [TBL] [Abstract][Full Text] [Related]
16. Informational needs of individuals from families harboring BRCA pathogenic variants: A systematic review and content analysis. Park SY; Kim Y; Kim S; Katapodi MC Genet Med; 2023 Apr; 25(4):100001. PubMed ID: 36549594 [TBL] [Abstract][Full Text] [Related]
17. Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center. Arun BK; Peterson SK; Sweeney LE; Bluebond RD; Tidwell RSS; Makhnoon S; Kushwaha AC Cancer; 2022 Jan; 128(1):94-102. PubMed ID: 34424535 [TBL] [Abstract][Full Text] [Related]
18. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families. Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680 [TBL] [Abstract][Full Text] [Related]
19. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not. Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844 [TBL] [Abstract][Full Text] [Related]
20. Extended Family Outreach in Hereditary Cancer Using Web-Based Genealogy, Direct-to-Consumer Ancestry Genetics, and Social Media: Mixed Methods Process Evaluation of the ConnectMyVariant Intervention. Chen AT; Huey J; Coe S; Kaganovsky J; Malouf EA; Evans HD; Daker J; Harper E; Fordiani O; Lowe EE; Oldroyd CM; Price A; Roth K; Stoddard J; Crandell JN; Shirts BH JMIR Cancer; 2023 Apr; 9():e43126. PubMed ID: 37079361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]